Miami Lawyer Leads Startup’s COVID-19 Screening Device to FDA Approval

Apr 06, 2021   
Print Friendly, PDF & Email

By Raychel Lean
April 06, 2021

Andrew S. Ittleman

A first-of-its-kind screening device for identifying COVID-19 biomarkers has secured emergency approval from the U.S. Food and Drug Administration, with the help of Miami’s Fuerst Ittleman founding partner Andrew S. Ittleman.

It took a year of “elbow grease, communication and patience” to get to this point, according to Ittleman, who said he’s learned the importance of building rapport and respect with the FDA, as it navigated a public health emergency.

To read more, click here.